FGFR3, HRAS and KRAS, along with known oncogene TP53, are typical biomarkers for bladder cancer associated with relevant pathways, and are discovered by EntCDP when K = 4 (Table S1.1 in S1 Data). This evidence concerns the gene FGFR3 and urinary bladder carcinoma.